Mohawk Valley Health System is a non-profit health system providing services to residents of the Mohawk Valley in Central New York. It was created in 2014 as an affiliation of Faxton St. Luke's Healthcare and St. Elizabeth Medical Center.

During the past decade, Faxton-Saint Luke's Healthcare conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 24 clinical trials were completed, i.e. on average, 160% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 18 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Faxton-Saint Luke's Healthcare" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Faxton-Saint Luke's Healthcare" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Breast Carcinoma" (3 trials), "Breast Adenocarcinoma" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Faxton-Saint Luke's Healthcare" in a lesser frequency.

Most popular intervention types in "Faxton-Saint Luke's Healthcare" are "Other" (28 trials), "Drug" (25 trials), "Biological" (19 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (9 trials), "Bevacizumab" (7 trials), "Docetaxel" (7 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Faxton-Saint Luke's Healthcare" are 25 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Faxton-Saint Luke's Healthcare". undefined are not yet recruiting, 2 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Faxton-Saint Luke's Healthcare, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Faxton-Saint Luke's Healthcare, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".